The Department of Health & Social Care (DHSC) has issued a revised interim protocol on dispensing adrenaline 150 microgram auto-injectors with immediate effect.

“Children weighing 25kg or less with the greatest short term need must still have access to these first, but stock positions are now sufficient to ensure that every patient has at least two 150microgram adrenaline auto injectors that are either in date or have a formally extended expiry date,” said DHSC.

A recent Supply Disruption Alert from DHSC on EpiPen and EpiPen Junior adrenaline auto-injectors (AAIs) advised controls on the supply of 150microgram AAIs to conserve supplies for patients who truly need them.

The latest alert asked to continue validating all prescriptions (private and NHS) prior to supply to the community pharmacy or dispensing doctor practice, for a named patient from the wholesaler, by utilising the revised flow chart.

The pharmacist must follow the flow chart of questions to ask patients to ascertain those who are in most need of supply, except when there is an immediate clinical need. They must explain the situation to patients/parents/carers.

DHSC has also published an updated FAQs on the supply issue.